Speckle-type POZ Protein is Negatively Associated with Malignancies and Inhibits Cell Proliferation and Migration in Liver Cancer

Yuping Huang,Ning Tan,Deshui Jia,Ying Jing,Qifeng Wang,Zhe Li,Jiwei Zhang,Li Liu,Jinjun Li,Zhiao Chen,Xianghuo He

DOI: https://doi.org/10.1007/s13277-015-3753-z

2015-01-01

Tumor Biology

Abstract:Speckle-type POZ protein (SPOP) is an E3 ubiquitin ligase adaptor that is frequently mutated in human cancers. Our previous findings have indicated that SPOP is mutated and functions as a novel tumor suppressor in hepatoblastoma (HB). However, the biological roles and clinical significance of this SPOP in hepatocellular carcinoma (HCC) remain unknown. In this study, we found that the expression level of SPOP was downregulated in HCC primary tumors by quantitative real-time PCR and the protein level of SPOP was also reduced in 72 pairs of HCC tissue microarrays by immunohistochemical analyses. Moreover, SPOP expression was observed to negatively correlate with the tumor grade and intrahepatic metastasis of HCC patients. Furthermore, we revealed that SPOP not only inhibits cell proliferation but also inhibits the motility of liver cancer cells. Finally, we discovered that one of the mechanisms through which SPOP inhibits liver cancer cell migration involves the disruption of ZEB2 expression and the associated epithelial-mesenchymal transition program. Together, our findings emphasize the critical role of SPOP in the regulation of proliferation and migration in liver cancer.